XML 105 R89.htm IDEA: XBRL DOCUMENT v3.8.0.1
Borrowings - Schedule of Financing Liabilities (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2017
Dec. 31, 2016
Debt Instrument [Line Items]    
HMBS-related borrowings [1] $ 4,358,277 $ 3,433,781
Other financing liabilities 536,981 579,031
Total Financing liabilities 4,895,258 4,012,812
Financing liability – MSRs pledged [Member]    
Debt Instrument [Line Items]    
Other financing liabilities 447,843 477,707
Financing liability – MSRs pledged [Member] | 2012 - 2013 Agreements [Member]    
Debt Instrument [Line Items]    
Other financing liabilities [2] 430,887 477,707
Financing liability – MSRs pledged [Member] | 2017 Agreements [Member]    
Debt Instrument [Line Items]    
Other financing liabilities [3] $ 16,956 0
Secured Notes, Ocwen Asset Servicing Income Series, Series 2014-1 [Member]    
Debt Instrument [Line Items]    
Maturity date [3] Feb. 28, 2028  
Other financing liabilities [4] $ 74,695 81,131
Financing Liability – Advances Pledged [Member]    
Debt Instrument [Line Items]    
Other financing liabilities [5] $ 14,443 $ 20,193
London Interbank Offered Rate (LIBOR) [Member]    
Debt Instrument [Line Items]    
Basis spread on variable rate [1] 2.64%  
[1] Represents amounts due to the holders of beneficial interests in Ginnie Mae guaranteed HMBS. The beneficial interests have no maturity dates, and the borrowings mature as the related loans are repaid.
[2] This financing liability arose in connection with sales proceeds received in 2012 and 2013 as part of the Rights to MSRs transactions with NRZ/HLSS and has no contractual maturity or repayment schedule. The balance of the liability is adjusted each reporting period to its fair value based on the present value of the estimated future cash flows underlying the related MSRs.
[3] This financing liability arose in connection with the lump sum payment received in September 2017 upon subsequently obtaining the required third-party consents and transfer of legal title of the MSRs related to the Rights to MSRs transactions with NRZ/HLSS in 2012 and 2013. We received a lump sum payment of $54.6 million as compensation for foregoing certain payments under the 2012 and 2013 agreements. This liability has no contractual maturity or repayment schedule. The balance of the liability is adjusted each reporting period to its fair value based on the present value of the estimated future cash flows. See Note 3 – Fair Value and Note 8 — Rights to MSRs for additional information.
[4] OASIS noteholders are entitled to receive a monthly payment amount equal to the sum of: (a) the designated servicing fee amount (21 basis points of the UPB of the reference pool of Freddie Mac mortgages); (b) any termination payment amounts; (c) any excess refinance amounts; and (d) the note redemption amounts, each as defined in the indenture supplement for the notes. We accounted for this transaction as a financing. Monthly amortization of the liability is estimated using the proportion of monthly projected service fees on the underlying MSRs as a percentage of lifetime projected fees, adjusted for the term of the security.
[5] Certain sales of advances did not qualify for sales accounting treatment and were accounted for as a financing. This financing liability has no contractual maturity.